Rep. Robert Bresnahan, Jr. Purchases Shares of Waters Co. (NYSE:WAT)

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Waters Co. (NYSE:WAT). In a filing disclosed on March 27th, the Representative disclosed that they had bought between $1,001 and $15,000 in Waters stock on February 25th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Intuit (NASDAQ:INTU) on 3/7/2025.
• Sold $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 3/6/2025.
• Purchased $1,001 – $15,000 in shares of SEA (NYSE:SE) on 3/5/2025.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Twilio (NYSE:TWLO) on 3/4/2025.
• Sold $15,001 – $50,000 in shares of Alibaba Group (NYSE:BABA) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Zoom Video Communications (NASDAQ:ZM) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 3/3/2025.
• Purchased $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 3/3/2025.

Waters Price Performance

Shares of WAT traded down $8.98 during trading hours on Friday, hitting $361.61. 277,709 shares of the stock were exchanged, compared to its average volume of 454,529. The stock’s 50-day moving average price is $387.41 and its two-hundred day moving average price is $372.60. The company has a market cap of $21.48 billion, a price-to-earnings ratio of 33.76, a price-to-earnings-growth ratio of 3.79 and a beta of 1.00. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. Waters Co. has a 12-month low of $279.24 and a 12-month high of $423.56.

Waters (NYSE:WAT) last released its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Research analysts expect that Waters Co. will post 12.86 earnings per share for the current year.

Analysts Set New Price Targets

WAT has been the topic of several recent analyst reports. Baird R W upgraded shares of Waters from a “hold” rating to a “strong-buy” rating in a report on Wednesday. Bank of America lowered their price objective on shares of Waters from $430.00 to $410.00 and set a “neutral” rating for the company in a research note on Thursday, February 13th. Sanford C. Bernstein raised Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price objective on the stock in a research report on Friday, January 10th. UBS Group lifted their target price on Waters from $405.00 to $410.00 and gave the company a “neutral” rating in a report on Thursday, February 13th. Finally, Robert W. Baird raised Waters from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $396.00 to $407.00 in a research report on Wednesday. Ten research analysts have rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, Waters presently has an average rating of “Moderate Buy” and an average price target of $397.40.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Waters by 15.9% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 4,318 shares of the medical instruments supplier’s stock worth $1,602,000 after purchasing an additional 593 shares during the period. Siemens Fonds Invest GmbH lifted its stake in Waters by 8,167.6% in the 4th quarter. Siemens Fonds Invest GmbH now owns 51,590 shares of the medical instruments supplier’s stock valued at $19,139,000 after buying an additional 50,966 shares in the last quarter. Menard Financial Group LLC acquired a new position in Waters in the 4th quarter valued at about $128,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Waters in the 4th quarter worth approximately $22,948,000. Finally, B. Riley Wealth Advisors Inc. acquired a new position in Waters in the fourth quarter valued at $223,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.